(Q28485972)

English

Treatment outcomes of treatment-naïve Hepatitis C patients co-infected with HIV: a systematic review and meta-analysis of observational cohorts

scientific article

In more languages

Statements

scholarly article

0 references

8 references

23 March 2019

21 March 2019

20 June 2019

22 June 2019

4 August 2019

19 October 2019

27 October 2020

25 October 2022

systematic review

1 reference

based on heuristic

1 reference

based on heuristic

Treatment outcomes of treatment-naïve Hepatitis C patients co-infected with HIV: a systematic review and meta-analysis of observational cohorts (English)

0 references

0 references

human immunodeficiency virus infectious disease

8 references

23 March 2019

21 March 2019

20 June 2019

22 June 2019

4 August 2019

19 October 2019

1 July 2020

27 October 2020

8 references

23 March 2019

21 March 2019

20 June 2019

22 June 2019

4 August 2019

19 October 2019

1 July 2020

27 October 2020

1 reference

4 August 2019

Retroviridae infectious disease

1 reference

19 October 2019

RNA virus infectious disease

1 reference

1 July 2020

antiviral agent

1 reference

27 October 2020

systematic review

1 reference

based on heuristic

1 reference

based on heuristic

object named as

Graham Cooke

6

0 references

Edward J. Mills

5

object named as

Edward J Mills

0 references

7

object named as

Nathan Ford

0 references

3

object named as

Zara Shubber

0 references

author name string

Anna Davies

1

0 references

Kasha P Singh

2

0 references

Philipp Ducros

4

0 references

language of work or name

0 references

publication date

5 February 2013

9 references

23 March 2019

21 March 2019

20 June 2019

22 June 2019

4 August 2019

19 October 2019

1 July 2020

27 October 2020

25 October 2022

9 references

23 March 2019

21 March 2019

20 June 2019

22 June 2019

4 August 2019

19 October 2019

1 July 2020

27 October 2020

25 October 2022

8

0 references

2

0 references

e55373

0 references

copyright license

Creative Commons Attribution 4.0 International

9 references

Europe PubMed Central

23 March 2019

Europe PubMed Central

21 March 2019

Europe PubMed Central

20 June 2019

Europe PubMed Central

22 June 2019

Europe PubMed Central

4 August 2019

Europe PubMed Central

19 October 2019

Europe PubMed Central

1 July 2020

Europe PubMed Central

27 October 2020

Europe PubMed Central

25 October 2022

copyright status

0 references

on focus list of Wikimedia project

0 references

Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

19 March 2017

Treatment of hepatitis C as prevention: a modeling case study in Vietnam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

19 March 2017

The influence of abacavir and other antiretroviral agents on virological response to HCV therapy among antiretroviral-treated HIV-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

19 March 2017

Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

19 March 2017

Hepatitis C Viral Kinetics During Treatment With Peg IFN-alpha-2b in HIV/HCV Coinfected Patients as a Function of Baseline CD4+ T-Cell Counts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

19 March 2017

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

19 March 2017

Measuring inconsistency in meta-analyses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

19 March 2017

Meta-analysis in clinical trials

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

19 March 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

29 September 2017

Influence of IL28B polymorphisms on response to a lower-than-standard dose peg-IFN-α 2a for genotype 3 chronic hepatitis C in HIV-coinfected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

19 March 2017

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

7 April 2017

Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

29 September 2017

Effectiveness of hepatitis B treatment in clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

29 September 2017

Circulating sCD14 is associated with virological response to pegylated-interferon-alpha/ribavirin treatment in HIV/HCV co-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

29 September 2017

Patient Characteristics Associated with HCV Treatment Adherence, Treatment Completion, and Sustained Virologic Response in HIV Coinfected Patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

29 September 2017

High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

29 September 2017

HCV RNA decline in the first 24 h exhibits high negative predictive value of sustained virologic response in HIV/HCV genotype 1 co-infected patients treated with peginterferon and ribavirin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

29 September 2017

Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

29 September 2017

Hepatitis C virus treatment rates and outcomes in HIV/hepatitis C virus co-infected individuals at an urban HIV clinic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

29 September 2017

Very early prediction of response to HCV treatment with PEG‐IFN‐alfa‐2a and ribavirin in HIV/HCV‐coinfected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

29 September 2017

Proteome-wide anti-hepatitis C virus (HCV) and anti-HIV antibody profiling for predicting and monitoring the response to HCV therapy in HIV-coinfected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

29 September 2017

Equitable access to HCV care in HIV-HCV co-infection can be achieved despite barriers to health care provision

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

29 September 2017

Peginterferon plus ribavirin for chronic hepatitis C in patients with human immunodeficiency virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

29 September 2017

Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

29 September 2017

Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

29 September 2017

Challenges in the treatment of patients coinfected with HIV and hepatitis C virus: need for team care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

29 September 2017

Optimizing hepatitis C therapy in HIV/hepatitis C virus (HCV) coinfected patients: Analysis of HCV viral kinetics on treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

2 June 2018

The basal activation state of DC subsets correlates with anti-HCV treatment outcome in HCV/HIV co-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

2 June 2018

Efficacy and tolerance of HCV treatment in HIV-HCV coinfected patients: the potential interaction of PI treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

2 June 2018

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055373

21 January 2018

A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055373

21 January 2018

Transformations Related to the Angular and the Square Root

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055373

21 January 2018

The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055373

21 January 2018

Effect of accompanying antiretroviral drugs on virological response to pegylated interferon and ribavirin in patients co-infected with HIV and hepatitis C virus

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055373

21 January 2018

Impact of hyperglycaemia and cholesterol levels on the outcome of hepatitis C virus (HCV) treatment in HIV/HCV-coinfected patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055373

21 January 2018

Similar hepatitis C virus RNA kinetics in HIV/hepatitis C virus monoinfected genotype 2 or 3 matched controls during hepatitis C virus combination therapy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055373

21 January 2018

Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055373

21 January 2018

Efficacy and safety of pegylated interferon plus ribavirin in HIV and hepatitis C virus-coinfected patients with advanced immunosuppression.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055373

21 January 2018

Chronic hepatitis C in HIV infection: feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055373

21 January 2018

Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055373

21 January 2018

Serum concentrations of ribavirin and pegylated interferon and viral responses in patients infected with HIV and HCV.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055373

21 January 2018

The cytotoxic lymphocyte antigen 4 polymorphisms affect response to hepatitis C virus-specific therapy in HIV(+) patients with acute and chronic hepatitis C virus co-infection.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055373

21 January 2018

Considerable under-treatment of chronic HCV infection in HIV patients despite acceptable sustained virological response rates in a real-life setting

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055373

21 January 2018

Therapeutical aspects and outcome of HIV/HCV coinfected patients treated with pegylated interferon plus ribavirin in an Italian cohort.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055373

21 January 2018

Efficacy and safety of pegylated interferon-alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055373

21 January 2018

Impact of peginterferon alpha-2b and ribavirin treatment on liver tissue in patients with HCV or HCV-HIV co-infection.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055373

21 January 2018

Improved cognitive function as a consequence of hepatitis C virus treatment

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055373

21 January 2018

Ability of treatment week 12 viral response to predict long-term outcome in genotype 1 hepatitis C virus/HIV coinfected patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055373

21 January 2018

Chronic hepatitis C in patients co-infected with human immunodeficiency virus in Japan: a retrospective multicenter analysis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055373

21 January 2018

Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055373

21 January 2018

Rate and timing of hepatitis C virus relapse after a successful course of pegylated interferon plus ribavirin in HIV-infected and HIV-uninfected patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0055373

21 January 2018

Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

27 November 2018

Sustained virological response according to the type of early virological response in HCV and HCV/HIV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

27 November 2018

Institute of Medicine recommendations for the prevention and control of hepatitis B and C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

27 November 2018

Treatment of chronic hepatitis C in patients with human immunodeficiency virus (HIV) with weekly peginterferon alpha-2b plus ribavirin: a multi-centred Belgian study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

27 November 2018

IP-10 correlates with hepatitis C viral load, hepatic inflammation and fibrosis and predicts hepatitis C virus relapse or non-response in HIV-HCV coinfection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

27 November 2018

Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3564801

27 November 2018

Why do the results of randomised and observational studies differ?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23393570

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0055373

0 references

2013PLoSO...855373D

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28485972&oldid=1968676347"